Results 301 to 310 of about 714,188 (330)
Some of the next articles are maybe not open access.

COX-2 inhibitors

The Lancet, 1999
In the past 100 years aspirin has demonstrated its value as an analgesic, anti-inflammatory, and antithrombotic agent. However, by 1938, it was clear that aspirin was gastrotoxic. Non-steroidal anti-inflammatory drugs (NSAIDs), developed since the 1960s, failed to achieve the goal of "a safer aspirin". The demonstration that inhibition of prostaglandin
  +12 more sources

COX-2 and Atherosclerosis

Journal of Cardiovascular Pharmacology, 2006
Inflammation plays a central role in the development of atherosclerotic disease, from the early phases of lesion formation to plaque disruption, the main underlying cause of acute ischemic syndromes. Arachidonic acid metabolism is implicated in the pathophysiology of ischemic syndromes affecting the coronary or cerebrovascular territory, as ...
CIPOLLONE, Francesco   +1 more
openaire   +3 more sources

COX-2 and the Kidneys

Current Pharmaceutical Design, 2000
The kidney is the second most frequent target of serious adverse effects of non-steroidal antiinflammatory drugs (NSAIDs). The renal side effects of NSAIDs related to inhibition of cyclooxygenase (COX) comprise reduction in renal blood flow (RBF) and glomerular filtration rate (GFR), sodium/water retention, water intoxication and hyperkalemia.
D O Stichtenoth, J C Frölich
openaire   +3 more sources

COX-2: Friend or Foe?

Current Pharmaceutical Design, 2007
It wasn't until 1990, when the existence of two different cyclooxygenases was hypothesized, based on the evidence that steroids inhibited the increase in COX activity induced by bacterial lipopolysaccharides in macrophages, without any effects on the basal production of prostaglandins or leukotrienes.
Iezzi A.   +3 more
openaire   +4 more sources

COX-2 in liver fibrosis

Clinica Chimica Acta, 2020
As a vital inducible sensor, cyclooxygenase-2 (COX-2) plays an important role in the progress of hepatic fibrogenesis. Activation of hepatic stellate cells (HSCs) in the liver can significantly accelerate the onset and development of liver fibrosis. COX-2 overexpression triggers inflammation that is an important inducer in hepatic fibrosis.
Hu Yang   +3 more
openaire   +2 more sources

COX-2 in Inflammation and Resolution

Molecular Interventions, 2006
Aspirin and the other NSAIDs have popularized the notion of inhibiting prostaglandins as a common anti-inflammatory strategy based on the erroneous premise that all eicosanoids are, within the context of inflammation, generally detrimental. However, our fascination with aspirin and the emergence of COX-2 has shown a more affable side to lipid mediators
Ravindra Rajakariar   +2 more
openaire   +3 more sources

COX-2 and the Kidney

Journal of Cardiovascular Pharmacology, 2006
Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for the treatment of pain and inflammation. Nonselective NSAIDs inhibit both cyclooxygenase (COX)-1 and COX-2. Nephrotoxicity of nonselective NSAIDs has been well documented. The effects of selective COX-2 inhibitors on renal function and blood pressure are attracting increasing attention ...
openaire   +3 more sources

Cox-2 expression in retinoblastoma

American Journal of Ophthalmology, 2000
Cox-2, a prostaglandin synthase, is overexpressed in colorectal cancers and is involved in angiogenesis as well as in tumorigenesis. In this study, we investigate the expression of Cox-2 in retinoblastoma.Twenty-nine formalin-fixed retinoblastoma specimens were examined by the labeled-streptavidin-biotin method using anti-Cox-2 antibody.Cox-2 positive ...
Yukihiro Imai   +5 more
openaire   +3 more sources

COX-2 and ALS

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 2001
(2001). COX-2 and ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders: Vol. 2, No. 3, pp. 121-122.
openaire   +2 more sources

COX-2 and prostaglandins in atherosclerosis

Lupus, 2005
Arachidonic acid metabolism is involved in acute ischemic syndromes affecting the coronary or cerebrovascular territory, as demonstrated by biochemical measurements of eicosanoid biosynthesis and the results of inhibitor trials in these settings. In particular, the efficacy of low-dose aspirin in reducing the complications of acute ischemic syndromes ...
openaire   +4 more sources

Home - About - Disclaimer - Privacy